VBI Vaccines Inc.
VBI Vaccines Inc.
VBIV

VBI Vaccines Inc. (VBIV)

$0.811.97%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.7738
Day's Range
$0.816
$0.6405
52-Week Range
$3.81
1 month return9.69%
3 month return52.78%
1 year return74.81%
5 year return82.08%

Company Information

VBI Vaccines Inc. is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI is advancing the prevention and treatment of hepatitis B, with: (1) the only 3-antigen hepatitis B vaccine, which is approved for use and commercially available in Israel under the name Sci-B-Vac® and completed its Phase 3 program in the U.S., Europe, and Canada in 2020; and (2) an immunotherapeutic in development for a functional cure for chronic hepatitis B. VBI's enveloped virus-like particle (eVLP) platform technology enables development of eVLPs that closely mimic the target virus to elicit a potent immune response. VBI's lead eVLP programs include a vaccine immunotherapeutic candidate targeting glioblastoma (GBM), a prophylactic cytomegalovirus (CMV) vaccine candidate, and a prophylactic coronavirus vaccine program. VBI is headquartered in Cambridge, MA, with research operations in Ottawa, Canada, and research and manufacturing facilities in Rehovot, Israel.
OrganizationVBI Vaccines Inc.
Employees130
CEO
IndustryHealth Technology

Analyst Recommendation

based on 9 analysts ratings

Buy
88%
Buy
11%
Hold
0%
Sell

Based on 9 Wall street analysts offering stock ratings for VBI Vaccines Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 723.46%

Current

$0.81

Target

$6.67

Recommendation Trend

Based on 9 analyst

Current1M Ago3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
333.2M
Book Value
0.56
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-0.27
PEG Ratio
0.0
Wall Street Target Price
6.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
527.97
Price/Book (mrq)
2.42
Enterprise Value
258.7M
Enterprise Value/Revenue
410.06
Enterprise Value/Ebitda
0.0

Technicals

Beta
1.96
50 Day MA
1.52
200 Day MA
2.44

Institutional Holdings

Perceptive Advisors LLC

20.26%

State Street Corporation

6.28%

BlackRock Inc

5.14%

Vanguard Group Inc

1.96%

Geode Capital Management, LLC

1.52%

CAMBRIDGE Invest RESEARCH ADVISORS, INC.

0.83%

Discover more

Frequently Asked Questions

What is VBI Vaccines Inc. share price today?

Can Indians buy VBI Vaccines Inc. shares?

How can I buy VBI Vaccines Inc. shares from India?

Can Fractional shares of VBI Vaccines Inc. be purchased?

What are the documents required to start investing in VBI Vaccines Inc. stocks?

What are today’s High and Low prices of VBI Vaccines Inc.?

What are today’s traded volumes of VBI Vaccines Inc.?

What is today’s market capitalisation of VBI Vaccines Inc.?

What is the 52 Week High and Low Range of VBI Vaccines Inc.?

How much percentage VBI Vaccines Inc. is down from its 52 Week High?

How much percentage VBI Vaccines Inc. is up from its 52 Week low?

What are the historical returns of VBI Vaccines Inc.?

Who is the Chief Executive Officer (CEO) of VBI Vaccines Inc.?